Literature DB >> 11355748

Effect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat.

H Raff1, E D Bruder, B M Jankowski, R J Colman.   

Abstract

The purpose of the present study was to evaluate the effect of exposure to hypoxia from birth to 7 days of age on leptin, insulin, growth hormone (GH), insulin-like growth factor-1 (IGF-1), glucose, corticosterone, body weight, and body composition in rats studied at 7 days of age and then after return to normoxia. Hypoxia for the first 7 days of life resulted in a significant decrease in plasma leptin, body weight, and an increase in corticosterone and insulin with no change in plasma glucose, GH or IGF-1. There was no significant effect of hypoxia on % lean body mass, but a small but significant increase in % body fat. Bone mineral density (BMD) was lower in 7-day-old hypoxic rats as compared to normoxic controls. All hormonal variables and BMD had normalized by 7 days after return to normoxia. However, body weight remained lower even 5 weeks after return to normoxia. We conclude that leptin is decreased during neonatal hypoxia despite no change in adiposity. Furthermore, insulin is increased probably to overcome the effects of increased counterregulatory hormones (such as corticosterone).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355748     DOI: 10.1055/s-2001-14929

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  17 in total

1.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

Review 2.  Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.

Authors:  Christine M Swanson; Steven A Shea; Katie L Stone; Jane A Cauley; Clifford J Rosen; Susan Redline; Gerard Karsenty; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

3.  Growth hormone therapy during neonatal hypoxia in rats: body composition, bone mineral density, and insulin-like growth factor-1 expression.

Authors:  H Raff; E D Bruder; B Jankowski; M K Oaks; R J Colman
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

4.  Microarray and real-time PCR analysis of adrenal gland gene expression in the 7-day-old rat: effects of hypoxia from birth.

Authors:  Eric D Bruder; Julie J Lee; Eric P Widmaier; Hershel Raff
Journal:  Physiol Genomics       Date:  2007-01-09       Impact factor: 3.107

5.  Adiponectin and resistin in the neonatal rat: effects of dexamethasone and hypoxia.

Authors:  Hershel Raff; Eric D Bruder
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  Sudden vs Pressure Wean From Nasal Continuous Positive Airway Pressure in Infants Born Before 32 Weeks of Gestation: A Randomized Clinical Trial.

Authors:  Christina Friis Jensen; Anna Sellmer; Finn Ebbesen; Rasa Cipliene; Anders Johansen; Rikke Monrad Hansen; Jens Peter Nielsen; Olga Hogreffe Nikitina; Jesper Padkær Petersen; Tine Brink Henriksen
Journal:  JAMA Pediatr       Date:  2018-09-01       Impact factor: 16.193

7.  Effect of hypoxia on parathyroid hormone in lactating and neonatal rats: interaction with halothane.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

8.  Augmented hypothalamic corticotrophin-releasing hormone mRNA and corticosterone responses to stress in adult rats exposed to perinatal hypoxia.

Authors:  H Raff; L Jacobson; W E Cullinan
Journal:  J Neuroendocrinol       Date:  2007-11       Impact factor: 3.627

9.  Total and active ghrelin in developing rats during hypoxia.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

10.  Short Hypoxia Does not Affect Plasma Leptin in Healthy Men under Euglycemic Clamp Conditions.

Authors:  Andre Schmoller; Michaela Voss; Hartmut Gehring; Sebastian Rudolf; Ulrich Schweiger; Bernd Schultes; Kerstin M Oltmanns
Journal:  Int J Endocrinol       Date:  2009-06-01       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.